第二阶段

我们是谁

  • 4 月 5, 2022
    The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
  • 4 月 5, 2022
    大肠癌机会之窗研究
  • 4 月 5, 2022
    达拉非尼 + 曲美替尼 + PDR001 在结直肠癌中的应用
  • 4 月 5, 2022
    伊帕塞替联合阿特珠单抗的试验
  • 4 月 5, 2022
    肿瘤诊断精准免疫肿瘤学和体细胞靶向合理性（TAPISTRY）平台研究
  • 4 月 5, 2022
    化疗栓塞（Lifepearls-伊立替康）在结直肠癌和转移性疾病患者中的应用
  • 4 月 5, 2022
    Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors
  • 4 月 5, 2022
    Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer
  • 4 月 5, 2022
    Phase I/II Trial of the Combination of Bintrafusp Alfa (M7824), Entinostat and NHS-IL12 (M9241) in Patients With Advanced Cancer
  • 4 月 5, 2022
    A Study of ALX148 With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer